An organosilicon compound, 2,6-cis-diphenylhexamethylcyclotetrasiloxane, cyclic 2,6-cis-[(PhMeSiO)2(Me2SiO)2], was shown to be an orally active estrogen in the mature castrate rat; about 1.0 mg/kg is equivalent to 0.005 mg/kg estradiol benzoate used as a maximum stimulatory dose in a uterotropic assay. Cyclic 2,6-cis-[(PhMeSiO)2(Me2SiO)2] is not an antiestrogen.Cyclic 2,6-cis-[(PhMeSiO)2(Me2SiO)2] is an effective oral postcoital antifertility agent when administered at 0.33 mg/kg on days 1-5 of gestation and at 3.0 mg/kg given on day 1 of gestation. The primary effect appeared to be accelerated passage of ova to the uterus and induction of ovum destruction in the oviduct. At the doses used cyclic 2,6-cis-[(PhMeSiO)2-(Me2SiO)2] was similar to diethylstilbestrol in that tubal retention did not occur as shown for estradiol benzoate. Administration of cyclic 2,6-cis-[(PhMeSiO)2(Me2SiO)2] at other times during gestation terminated pregnancy during primitive streak and neurula stages (days 8-11). Gestation was less sensitive to organosiloxane treatment during implantation. Pregnancy was not terminated after day 11. Thus, this purely organosilicon compound represents a new class of moderate estrogens and may be useful in the study of estrogen structure-activity relationships.